Cancer prevention research
that doesn't insult your intelligence.
We analyze clinical trials, meta-analyses, and emerging evidence on cancer prevention and repurposed treatments. Every claim gets an evidence grade. No miracle cures. Just research.
Our Evidence Grading System
Every compound and intervention gets a grade based on the quality of human clinical evidence, not animal studies or test tubes.
Latest Research
High-Dose IV Vitamin C: The Trial That Doubled Survival
A Phase II RCT doubled overall survival in metastatic pancreatic cancer. We break down the Iowa trial, mechanism, and what it means.
⭐ Grade A: Strong EvidenceMebendazole: The $5 Cancer Drug
An FDA-approved dewormer with Phase I/II trial data in glioblastoma and colorectal cancer. Crosses the blood-brain barrier.
🔬 Grade B: PromisingThe Galleri Test: Is $950/yr Worth It?
A blood test that detects 50 cancer types. The PATHFINDER 2 trial showed 7x cancer detection. We analyze what that actually means.
⭐ Grade A: Strong EvidenceHigh-Dose Melatonin: The 34% Mortality Reduction
Meta-analysis of 8 RCTs shows melatonin at 10-20mg (not sleep doses) reduced cancer mortality by 34%. No toxicity ever established.
🔬 Grade B: PromisingWhy Metformin Failed for Cancer
The MA.32 trial (3,649 patients) killed the metformin-cancer hypothesis. HR 1.01. We explain what went wrong with the observational data.
⚠️ Grade D: Weak / MixedThe Anti-Cancer Protocol: Daily, Weekly, Monthly
An evidence-ranked stack of interventions from free (fasting, exercise) to prescription (rapamycin). Every item graded.
⭐ Grade A: Strong EvidenceNew research reviews every month.
We track clinical trials, emerging compounds, and AI-driven cancer discoveries. Get updates when we publish new evidence reviews.